ABOUT TERRA LUMINA
We are Terra Lumina, an international team of scientists & technologists.
We work relentlessly on harnessing the power of AI to unlock the therapeutic potential of nature's small molecules, delivering meaningful medicines to patients around the world.
Our Values
Committed to healthcare
Scientific Rigor
We believe that the rigorous, ethical and thoughtful application of science is key to the creation of groundbreaking medicine.
Respect
Committed to upholding the rights and respecting the biodiversity and ethnobotanical knowledge of local communities and countries.
Patient Centric
Our core mission is to create meaningful medicines that bring value to patients
TEAM
Leadership
Andreas Bender, PhD
Lead Scientific Advisor
Andreas is a world-renowned expert with 18+ years working in the space of AI in Drug Discovery as well as in cheminformatics. He has led a group at the University of Cambridge in Molecular Informatics for the last 10 years, and his scientific work has been cited more than 14,000 times. He was previously the Co-founder & CTO of Healx, a drug discovery company targeting rare diseases. Andreas has also worked on AI drug discovery teams at AstraZeneca & Novartis.
TEAM
Core team
Camila Caldana, PhD
Scientific & Data Partnerships;
Plant metabolomics lead
Yoann Gloaguen, PhD
Senior Cheminformatician
Metabolomics
Vijay Ingalalli, PhD
Knowledge Graph Engineer
Antonella Tsoukala
Business Development
Patrick Tjandra
Business Development
Philipp Wiedmann
Business Development
Advisory Board
Scientific
Sebastian Böcker, PhD
Business Development
Chris Swain, PhD
Business Development
Justin J.J. van Hooft, PhD
Business Development
Christoph Steinbeck, PhD
Business Development
Florian Huber, PhD
Business Development
Christian Zidorn, PhD
Business Development
Tai-Ping Fan, PhD
Business Development
Kalpana Joshi, PhD
Business Development
Jean-Loup Faulon, PhD
Business Development
DISCOVER WITH US
Our partnership models
Discovery Partnerships
Work with us to identify novel compounds, powering your early-stage discovery pipeline. We screen our rich & diverse library of natural compound scaffolds to provide high-value lead candidates for co-development.
License our proprietary candidates
We are building a portfolio of validated lead candidates in key therapeutic areas. Contact us to learn more about our proprietary pipeline of leads.
